Evidence map›Paper›PMID 42368080›Full record

ArticleACS omega2026

Unlabeled but Not Unseen: Cytotoxicity Classification of Re(I) Tricarbonyl Complexes via K‑Means Clustering.

Miroslava Nedyalkova, Gozde Demirci, Youri Cortat, Lilai Abraha, Aurelien Crochet, Marco Lattuada, Fabio Zobi

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miroslava NedyalkovaDepartment of Chemistry, University of Fribourg, Chemin Du Musée 9, 1700 Fribourg, Switzerland.ORCID https://orcid.org/0000-0003-0793-3340
Gozde DemirciDepartment of Chemistry, University of Fribourg, Chemin Du Musée 9, 1700 Fribourg, Switzerland.
Youri CortatDepartment of Chemistry, University of Fribourg, Chemin Du Musée 9, 1700 Fribourg, Switzerland.
Lilai AbrahaDepartment of Chemistry, University of Fribourg, Chemin Du Musée 9, 1700 Fribourg, Switzerland.
Aurelien CrochetDepartment of Chemistry, University of Fribourg, Chemin Du Musée 9, 1700 Fribourg, Switzerland.ORCID https://orcid.org/0000-0002-4763-2764
Marco LattuadaDepartment of Chemistry, University of Fribourg, Chemin Du Musée 9, 1700 Fribourg, Switzerland.ORCID https://orcid.org/0000-0001-7058-9509
Fabio ZobiDepartment of Chemistry, University of Fribourg, Chemin Du Musée 9, 1700 Fribourg, Switzerland.ORCID https://orcid.org/0000-0002-9077-7184

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prediction of cytotoxicity for metal-based drug candidates remains a significant challenge due to the structural diversity and multifactorial mechanisms of action inherent to transition metal complexes. Here, we present an unsupervised machine learning approach employing K-means clustering to cluster the cytotoxicity of 225 rhenium-(I) tricarbonyl complexes based solely on molecular descriptors. After comprehensive descriptor calculation and reduction, principal component analysis was used to assess chemical space coverage and identify key variables. K-means clustering, applied without prior toxicity labels, successfully partitioned the data set into cytotoxic and noncytotoxic clusters, achieving high concordance with known biological activity and accurately clustering control compounds. Analysis of misclassified cases provided further insight into structural motifs associated with ambiguous toxicity profiles. This work demonstrates that K-means clustering, when integrated with robust descriptor selection and PCA, offers a transparent, efficient, and interpretable framework for early stage toxicity assessment in metal-based drug discovery, particularly when labeled data are limited.

Identifiers

PMID42368080
PMCPMC13295016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.